A Fung 100MG Cap
BIOCEUTICS - capsule - 100 mg - 10 S
Standard delivery
Distributor inventory | Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated August 2026
Medicines with the same active ingredient and strength as Vildaglip M Tab.
You are viewing
Vildaglip M Tab
tablet - 10 S
₹94
₹9.38 per tablet
MANKIND (PHARMA) · tablet - 15 S · Rx
₹85
₹5.66 per tablet
RISEMARKER PHARMACEUTICALS · tablet - 50 mg - 10 S · Rx
₹65
₹6.47 per tablet
Vildagliptin (50mg)
Treatment of type 2 diabetes mellitus to improve glycaemic control along with diet and exercise.
Vildagliptin is a DPP-4 inhibitor that increases incretin levels, enhancing insulin release and reducing glucagon secretion in a glucose-dependent manner. Metformin decreases hepatic glucose production and improves insulin sensitivity, lowering blood glucose levels.
Take by mouth as prescribed by a doctor, usually with meals to reduce stomach upset. Swallow tablet whole with water; do not crush/chew unless advised. Regularly monitor blood glucose and follow diet/exercise advice.
Common side effects of Vildaglip M Tab may include:
BIOCEUTICS - capsule - 100 mg - 10 S
Standard delivery
BIOCEUTICS - capsule - 130 mg - 10 S
Standard delivery

BIOCEUTICS - capsule - 10 S
Standard delivery

BIOCEUTICS - 10 S
Standard delivery
BIOCEUTICS - capsule - 8 mg - 10 S
Standard delivery

BIOCEUTICS - 300 g
Standard delivery

BIOCEUTICS - 300 g
Standard delivery

BIOCEUTICS - 300 g
Standard delivery
STATURE LIFE SCIENCES PRIVATE · tablet - 10 S · Rx
₹81
₹8.05 per tablet
A substitute contains the same active ingredient (salt), in the same strength, as Vildaglip M Tab. The medicine inside is the same — the brand name, manufacturer and price are what differ.
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.
Type 1 diabetes and diabetic ketoacidosis: not indicated. Metformin can rarely cause lactic acidosis—risk increases with kidney impairment, dehydration, severe infection, hypoxia/heart failure, excessive alcohol use; assess renal function before and during therapy. Vildagliptin may affect liver enzymes—periodic liver function tests recommended; stop if jaundice or significant LFT rise. Use caution in elderly and in renal/hepatic impairment; dose adjustments may be required. Temporarily stop metformin around iodinated contrast procedures and major surgery as advised by doctor. Watch for symptoms of pancreatitis (severe abdominal pain) and severe allergic reactions; seek medical help.